Paramount Supplements introduces Ergopharm's 11-OXO, the first selective inhibitor of 11b-hydroxysteroid dehydrogenase type I reductase. Finally, cortisol control that delivers on the promises.
Ergopharm has found the key to obtaining:
Decreased body fat (especially visceral adipose tissue)
Increased muscle density (hardness)
Enhanced insulin sensitivity and glycogen deposition